+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report By Product (Media, Sera), By End-use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 200 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899475
Description Jump to:
The global cell therapy raw materials market size is anticipated to reach USD 19.77 billion by 2030. The market is projected to grow at a CAGR of 24.47%. The rising investments in the research and development of various cell-based drugs and the increasing number of government investments in numerous countries for various clinical studies are anticipated to contribute to the growth of the market. Moreover, the growing developments in the biopharmaceutical & biotechnology industry in developing countries are further fueling the growth of the market over the forecast period.

The COVID-19 pandemic had a significant impact on the cell therapy raw materials industry. As the virus spread globally, disruptions in supply chains, workforce shortages, and transportation restrictions posed significant challenges to the production and distribution of critical raw materials required for cell therapy manufacturing. Many suppliers faced delays in the sourcing and delivery of essential components, such as growth factors, culture media, and bioreactors. This resulted in production slowdowns and increased costs for cell therapy companies. In addition, the heightened demand for medical supplies during the pandemic strained resources and led to price fluctuations. Despite these challenges, the cellular therapy industry demonstrated resilience by adapting to new sourcing strategies and regulatory changes, emphasizing the importance of supply chain diversification and preparedness in the face of unforeseen global crises.

Moreover, the cell therapy industry is anticipated to witness a significant surge in advancements and innovations by biopharma companies. These advances would be further propelled by the growing demand for effective cell-based therapies to treat a range of diseases and medical conditions. Furthermore, the growing expansion of various biotechnology and pharmaceutical companies is further expected to propel the growth of the market over the forecast period.

The increasing expansion of cellular therapy manufacturing along with rising FDA approvals are opening numerous opportunities for the raw materials market. Several manufacturers are opening such facilities to increase their footprint in the cellular therapy field. For instance, in June 2023, Bristol Myers Squibb received approval from the U.S. FDA to start its commercial production at its new cell therapy production facility in Devens, Massachusetts. For the long-term supply of the company's therapy portfolio, the Devens site is a crucial part of BMS' growing worldwide cell therapy production infrastructure.

However, the cost and affordability restrain the growth of the market. These materials, vital for cell therapy production, are costly to obtain and manufacture. This cost burden increases the expenses in the development and provision of cell-based therapies, potentially limiting their accessibility to a broader population due to financial constraints. Balancing quality and affordability is an acute concern in advancing cell therapies and ensuring their broader availability and acceptance within the healthcare industry.

Cell Therapy Raw Materials Market Report Highlights

  • Based on product, the media segment held the largest revenue share of 24.20% in 2022. This is attributed to the increasing clinical trials for the drug discovery and development process. On the other hand, the antibodies segment is anticipated to witness the fastest CAGR of 27.55% over the forecast period
  • Based on end-use, the biopharmaceutical & pharmaceutical companies segment held the largest market share of 53.70% in 2022. Due to the increasing number of research activities for drug discoveries & development and the growing demand for personalized medicines, the demand for raw materials in cell therapy is projected to boost over a period of time
  • Based on region, North America dominated the market with a share of 45.98% in 2022, owing to the presence of major market players, and well-established healthcare infrastructure. These factors are anticipated to boost the market in the region during the study period. Asia Pacific is anticipated to witness the fastest CAGR of 24.96% over the forecast period


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising demand for cell therapies
3.2.1.2. Advancements in research and development for cell-based therapies
3.2.1.3. Technological Innovation
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with the production and procurement of raw materials
3.2.2.2. Stringent regulations associated with cell therapies
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Cell Therapy Raw Materials Market: Product Movement Analysis
4.2. Media
4.2.1. Media Market, 2018 - 2030 (USD Million)
4.3. Sera
4.3.1. Sera Market, 2018 - 2030 (USD Million)
4.4. Cell Culture Supplements
4.4.1. Cell Culture Supplements Market, 2018 - 2030 (USD Million)
4.5. Antibodies
4.5.1. Antibodies Market, 2018 - 2030 (USD Million)
4.6. Reagents & Buffers
4.6.1. Reagents & Buffers Market, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. End-use Business Analysis
5.1. Cell Therapy Raw Materials Market: End-use Movement Analysis
5.2. Biopharmaceutical & Pharmaceutical Companies
5.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
5.3. CROs & CMOs
5.3.1. CROs & CMOs Market, 2018 - 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Cell Therapy Raw Materials Market Share By Region, 2022 & 2030
6.2. North America
6.2.1. North America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Competitive Scenario
6.2.2.3. Regulatory Framework
6.2.2.4. U.S. Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. Regulatory Framework
6.2.3.4. Canada Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. UK Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Germany Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. France Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Regulatory Framework
6.3.5.4. Italy Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Regulatory Framework
6.3.6.4. Spain Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Regulatory Framework
6.3.7.4. Denmark Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Regulatory Framework
6.3.8.4. Sweden Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Regulatory Framework
6.3.9.4. Norway Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Japan Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. China Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. India Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Australia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Thailand Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. South Korea Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Brazil Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Mexico Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Argentina Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. MEA Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. South Africa Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Saudi Arabia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. UAE Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Kuwait Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Share/Position Analysis, 2022
7.4. Company Profiles
7.4.1. Thermo Fisher Scientific Inc.
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Merck KGaA
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Actylis.
7.4.3.1. Overview F
7.4.3.2. Product Benchmarking
7.4.3.3. Strategic Initiatives
7.4.4. ACROBiosystems
7.4.4.1. Overview
7.4.4.2. Product Benchmarking
7.4.4.3. Strategic Initiatives
7.4.5. STEMCELL Technologies
7.4.5.1. Overview
7.4.5.2. Product Benchmarking
7.4.5.3. Strategic Initiatives
7.4.6. Grifols, S.A.
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Charles River Laboratories
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. RoosterBio, Inc.
7.4.8.1. Overview
7.4.8.2. Product Benchmarking
7.4.8.3. Strategic Initiatives
7.4.9. PromoCell GmbH
7.4.9.1. Overview
7.4.9.2. Product Benchmarking
7.4.9.3. Strategic Initiatives
7.4.10. Danaher
7.4.10.1. Overview
7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Sartorius Stedim Biotech
7.4.11.1. Overview
7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives
List of Tables
Table 1 Global cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 2 Global cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 3 Global cell therapy raw materials market, by region, 2018-2030 (USD Million)
TABLE 4 North America cell therapy raw materials market, by country, 2018-2030 (USD Million)
TABLE 5 North America cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 6 North America cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 7 U.S. cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 8 U.S. cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 9 Canada cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 10 Canada cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 11 Europe cell therapy raw materials market, by country, 2018-2030 (USD Million)
TABLE 12 Europe cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 13 Europe cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 14 UK cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 15 UK cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 16 Germany cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 17 Germany cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 18 France cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 19 France cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 20 Italy cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 21 Italy cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 22 Spain cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 23 Spain cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 24 Denmark cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 25 Denmark cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 26 Sweden cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 27 Sweden cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 28 Norway cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 29 Norway cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 30 Asia Pacific cell therapy raw materials market, by country, 2018-2030 (USD Million)
TABLE 31 Asia Pacific cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 32 Asia Pacific cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 33 Japan cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 34 Japan cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 35 China cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 36 China cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 37 India cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 38 India cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 39 Australia cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 40 Australia cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 41 South Korea cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 42 South Korea cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 43 Thailand cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 44 Thailand cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 45 Latin America cell therapy raw materials market, by country, 2018-2030 (USD Million)
TABLE 46 Latin America cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 47 Latin America cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 48 Brazil cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 49 Brazil cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 50 Mexico cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 51 Mexico cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 52 Argentina cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 53 Argentina cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 54 Middle East & Africa cell therapy raw materials market, by country, 2018-2030 (USD Million)
TABLE 55 Middle East & Africa cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 56 Middle East & Africa cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 57 South Africa cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 58 South Africa cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 59 Saudi Arabia cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 60 Saudi Arabia cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 61 UAE cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 62 UAE cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 63 Kuwait cell therapy raw materials market, by product, 2018-2030 (USD Million)
TABLE 64 Kuwait cell therapy raw materials market, by end-use, 2018-2030 (USD Million)
TABLE 65 Key companies undertaking acquisitions
TABLE 66 Key companies launching new products/services
TABLE 67 Key companies undertaking collaborations and partnerships
TABLE 68 Key companies undertaking other initiatives
List of Figures
Fig. 1 Market research process
FIG. 2 Cell therapy raw materials market segmentation
FIG. 3 Data analysis models
FIG. 4 Market formulation and validation
FIG. 5 Data validating & publishing
FIG. 6 Market research process
FIG. 7 Information procurement
FIG. 8 Primary research
FIG. 9 Value-chain-based sizing & forecasting
FIG. 10 QFD modeling for market share assessment
FIG. 11 Market formulation & validation
FIG. 12 Commodity flow analysis
FIG. 13 Market snapshot
FIG. 14 Segment snapshot
FIG. 15 Segment snapshot
FIG. 16 Competitive landscape snapshot
FIG. 17 Market trends & outlook
FIG. 18 India disposable income, 2018-2020 (INR Million)
FIG. 19 Porter’s five force analysis
FIG. 20 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
FIG. 21 Cell therapy raw materials market: product outlook key takeaways
FIG. 22 Cell therapy raw materials market: product movement analysis
FIG. 23 Media market, 2018-2030 (USD Million)
FIG. 24 Sera market, 2018-2030 (USD Million)
FIG. 25 Cell culture supplements market, 2018-2030 (USD Million)
FIG. 26 Antibodies market, 2018-2030 (USD Million)
FIG. 27 Reagents & buffers market, 2018-2030 (USD Million)
FIG. 28 Others market, 2018-2030 (USD Million)
FIG. 29 Cell therapy raw materials market: end-use outlook key takeaways
FIG. 30 Cell therapy raw materials market: end-use movement analysis
FIG. 31 Biopharmaceutical & pharmaceutical companies market, 2018-2030 (USD Million)
FIG. 32 CROs & CMOs supplements market, 2018-2030 (USD Million)
FIG. 33 Others supplements market, 2018-2030 (USD Million)
FIG. 34 Cell therapy raw materials market revenue, by region, 2022 & 2030, (USD Million)
FIG. 35 Regional marketplace: key takeaways
FIG. 36 North America cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 37 US cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 38 US Key country dynamics
FIG. 39 Canada cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 40 Canada Key country dynamics
FIG. 41 Europe cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 42 UK cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 43 UK Key country dynamics
FIG. 44 Germany cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 45 Germany Key country dynamics
FIG. 46 France cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 47 France Key country dynamics
FIG. 48 Spain cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 49 Spain Key country dynamics
FIG. 50 Italy cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 51 Italy Key country dynamics
FIG. 52 Denmark cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 53 Denmark Key country dynamics
FIG. 54 Sweden cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 55 Sweden Key country dynamics
FIG. 56 Norway cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 57 Norway Key country dynamics
FIG. 58 Asia Pacific cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 59 Japan cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 60 Japan Key country dynamics
FIG. 61 China cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 62 China Key country dynamics
FIG. 63 India cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 64 India Key country dynamics
FIG. 65 Australia cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 66 Australia Key country dynamics
FIG. 67 South Korea cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 68 South Korea Key country dynamics
FIG. 69 Thailand cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 70 Thailand Key country dynamics
FIG. 71 Latin America cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 72 Brazil cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 73 Brazil Key country dynamics
FIG. 74 Mexico cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 75 Mexico Key country dynamics
FIG. 76 Argentina cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 77 Argentina Key country dynamics
FIG. 78 MEA cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 79 South Africa cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 80 South Africa Key country dynamics
FIG. 81 Saudi Arabia cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 82 Saudi Arabia Key country dynamics
FIG. 83 UAE cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 84 UAE Key country dynamics
FIG. 85 Kuwait cell therapy raw materials market estimates and forecasts, 2018-2030 (USD Million)
FIG. 86 Kuwait Key country dynamics
FIG. 87 Market participant categorization
FIG. 88 Strategic framework

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Actylis.
  • ACROBiosystems
  • STEMCELL Technologies
  • Grifols, S.A.
  • Charles River Laboratories
  • RoosterBio, Inc.
  • PromoCell GmbH
  • Danaher
  • Sartorius Stedim Biotech

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages200
PublishedOctober 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 3.46 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.77 Billion
Compound Annual Growth Rate24.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Global Cell Therapy Human Raw Materials Market Size, Share & Trends Analysis Report, Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements), End Use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Cell Therapy Human Raw Materials Market Size, Share & Trends Analysis Report, Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements), End Use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Global Cell Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), Therapeutic Area, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Cell Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), Therapeutic Area, Region, and Segment Forecasts, 2024-2030

  • Report
  • 110 Pages
  • Global
From
Global Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Forecast 2024-2030 - Product Image

Global Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Global Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Forecast 2023-2030 - Product Image

Global Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Forecast 2023-2030

  • Report
  • 181 Pages
  • Global
From
Global Cell Therapy Raw Materials Market Analysis & Forecast to 2024-2034: Market By Product; By End-user; and By Region - Product Image

Global Cell Therapy Raw Materials Market Analysis & Forecast to 2024-2034: Market By Product; By End-user; and By Region

  • Report
  • 200 Pages
  • Global
From

About the Cell Therapy Raw Materials Market

Cell therapy raw materials are biotechnological products used in the production of cell therapies. These materials are used to create cell therapies, which are treatments that involve the use of living cells to treat or prevent diseases. Cell therapy raw materials include cell culture media, reagents, and other components used in the production of cell therapies. These materials are essential for the production of cell therapies, as they provide the necessary nutrients and environment for the cells to grow and develop. Cell therapy raw materials are used in a variety of industries, including biopharmaceuticals, regenerative medicine, and tissue engineering. The cell therapy raw materials market is expected to grow significantly in the coming years due to the increasing demand for cell therapies. Some companies in the cell therapy raw materials market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Corning Incorporated, and Sigma-Aldrich. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.